The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model

  • Lee, Hwayoung (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Im, Jiyun (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Won, Hansol (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Nam, Wooyoung (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Kim, Young Ock (Development of Ginseng and Medical Plants Research Institute, Rural Administration) ;
  • Lee, Sang Won (Development of Ginseng and Medical Plants Research Institute, Rural Administration) ;
  • Lee, Sanghyun (Department of Integrative Plant Science, ChungAng University) ;
  • Cho, Ik-Hyun (Department of Convergence Medical Science, Brain Korea 21 Plus Program, and Institute of Korean Medicine, College of Oriental Medicine, Kyung Hee University) ;
  • Kim, Hyung-Ki (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Kwon, Jun-Tack (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University) ;
  • Kim, Hak-Jae (Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University)
  • Received : 2016.11.26
  • Accepted : 2017.04.28
  • Published : 2017.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Previous reports have suggested that physical and psychological stresses may trigger fibromyalgia (FM). Stress is an important risk factor in the development of depression and memory impairments. Antidepressants have been used to prevent stress-induced abnormal pain sensation. Among various antidepressants, tianeptine has been reported to be able to prevent neurodegeneration due to chronic stress and reverse decreases in hippocampal volume. To assess the possible effect of tianeptine on FM symptoms, we constructed a FM animal model induced by restraint stress with intermittent cold stress. All mice underwent nociceptive assays using electronic von Frey anesthesiometer and Hargreaves equipment. To assess the relationship between tianeptine and expression levels of brain-derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB), and phosphorylated cAMP response element-binding protein (p-CREB), western blotting and immunohistochemistry analyses were performed. In behavioral analysis, nociception tests showed that pain threshold was significantly decreased in the FM group compared to that in the control group. Western blot and immunohistochemical analyses of medial prefrontal cortex (mPFC) and hippocampus showed downregulation of BDNF and p-CREB proteins in the FM group compared to the control group. However, tianeptine recovered these changes in behavioral tests and protein level. Therefore, this FM animal model might be useful for investigating mechanisms linking BDNF-CREB pathway and pain. Our results suggest that tianeptine might potentially have therapeutic efficacy for FM.

Keywords

References

  1. Clauw DJ. Fibromyalgia: more than just a musculoskeletal disease. Am Fam Physician. 1995;52:843-851, 853-854.
  2. Rohrbeck J, Jordan K, Croft P. The frequency and characteristics of chronic widespread pain in general practice: a case-control study. Br J Gen Pract. 2007;57:109-115.
  3. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244-1252. https://doi.org/10.1001/jama.1992.03480090092034
  4. Bardin L, Malfetes N, Newman-Tancredi A, Depoortere R. Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies. Behav Brain Res. 2009;205:360-366. https://doi.org/10.1016/j.bbr.2009.07.005
  5. Nishiyori M, Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain. 2008;4:52.
  6. Magarinos AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience. 1995;69:89-98. https://doi.org/10.1016/0306-4522(95)00259-L
  7. Zafir A, Banu N. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress. 2009;12:167-177. https://doi.org/10.1080/10253890802234168
  8. Goffer Y, Xu D, Eberle SE, D'amour J, Lee M, Tukey D, Froemke RC, Ziff EB, Wang J. Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci. 2013;33:19034-19044. https://doi.org/10.1523/JNEUROSCI.2454-13.2013
  9. Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, Radulovic J, Martina M, Miller RJ, Apkarian AV. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012;32:5747-5756. https://doi.org/10.1523/JNEUROSCI.0587-12.2012
  10. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC. Stress and IL-1beta contribute to the development of depressivelike behavior following peripheral nerve injury. Mol Psychiatry. 2010;15:404-414. https://doi.org/10.1038/mp.2009.91
  11. De Ryck LM, Raus JC. Superfusion of normal and neoplastic mouse mammary tissue with estrogens. Endocrinology. 1983;113:399-408. https://doi.org/10.1210/endo-113-1-399
  12. Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL. Multidisciplinary care and stepwise treatment for fibromyalgia. J Clin Psychiatry. 2008;69:e35. https://doi.org/10.4088/JCP.1208e35
  13. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: a randomized, doubleblind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336-1344. https://doi.org/10.1002/art.22457
  14. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G. A 14-week, randomized, doubleblinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9:792-805. https://doi.org/10.1016/j.jpain.2008.03.013
  15. M'Dahoma S, Barthelemy S, Tromilin C, Jeanson T, Viguier F, Michot B, Pezet S, Hamon M, Bourgoin S. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats. Eur Neuropsychopharmacol. 2015;25:2118-2130. https://doi.org/10.1016/j.euroneuro.2015.07.026
  16. Schmidt-Kastner R, Wetmore C, Olson L. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience. 1996;74:161-183. https://doi.org/10.1016/0306-4522(96)00093-0
  17. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59:1116-1127. https://doi.org/10.1016/j.biopsych.2006.02.013
  18. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003;54:70-75. https://doi.org/10.1016/S0006-3223(03)00181-1
  19. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism. 2005;54(5 Suppl 1):20-23. https://doi.org/10.1016/j.metabol.2005.01.008
  20. Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell'Osso L. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord. 2008;105:279-283. https://doi.org/10.1016/j.jad.2007.05.005
  21. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64:527-532. https://doi.org/10.1016/j.biopsych.2008.05.005
  22. Miletic G, Miletic V. Increases in the concentration of brain derived neurotrophic factor in the lumbar spinal dorsal horn are associated with pain behavior following chronic constriction injury in rats. Neurosci Lett. 2002;319:137-140. https://doi.org/10.1016/S0304-3940(01)02576-9
  23. Guo JQ, Deng HH, Bo X, Yang XS. Involvement of BDNF/TrkB and ERK/CREB axes in nitroglycerin-induced rat migraine and effects of estrogen on these signals in the migraine. Biol Open. 2017;6:8-16. https://doi.org/10.1242/bio.021022
  24. Bhatt DK, Ramachandran R, Christensen SL, Gupta S, Jansen-Olesen I, Olesen J. CGRP infusion in unanesthetized rats increases expression of c-Fos in the nucleus tractus solitarius and caudal ventrolateral medulla, but not in the trigeminal nucleus caudalis. Cephalalgia. 2015;35:220-233. https://doi.org/10.1177/0333102414535995
  25. Buldyrev I, Tanner NM, Hsieh HY, Dodd EG, Nguyen LT, Balkowiec A. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem. 2006;99:1338-1350. https://doi.org/10.1111/j.1471-4159.2006.04161.x
  26. Yajima Y, Narita M, Narita M, Matsumoto N, Suzuki T. Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice. Brain Res. 2002;958:338-346. https://doi.org/10.1016/S0006-8993(02)03666-1
  27. Clauw DJ. Fibromyalgia: an overview. Am J Med. 2009;122(12 Suppl):3S-13S.
  28. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressantlike effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 1997;56:131-137. https://doi.org/10.1016/S0091-3057(96)00169-4
  29. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brainderived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22:3251-3261. https://doi.org/10.1523/JNEUROSCI.22-08-03251.2002
  30. Schmidt HD, Duman RS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology. 2010;35:2378-2391. https://doi.org/10.1038/npp.2010.114
  31. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:7539-7547. https://doi.org/10.1523/JNEUROSCI.15-11-07539.1995
  32. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 1996;16:2365-2372. https://doi.org/10.1523/JNEUROSCI.16-07-02365.1996
  33. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010;15:237-249. https://doi.org/10.1038/mp.2009.80
  34. Watson PN, Merskey H. Antidepressant analgesics in pain management. Encyclopedia of Pain. 2007;100-104.
  35. Uzbay IT, Cinar MG, Aytemir M, Tuglular I. Analgesic effect of tianeptine in mice. Life Sci. 1999;64:1313-1319. https://doi.org/10.1016/S0024-3205(99)00066-1
  36. Chu CC, Wang JJ, Chen KT, Shieh JP, Wang LK, Shui HA, Ho ST. Neurotrophic effects of tianeptine on hippocampal neurons: a proteomic approach. J Proteome Res. 2010;9:936-944. https://doi.org/10.1021/pr900799b
  37. Kim WM, Lee SH, Jeong HJ, Lee HG, Choi JI, Yoon MH. The analgesic activity of intrathecal tianeptine, an atypical antidepressant, in a rat model of inflammatory pain. Anesth Analg. 2012;114:683-689. https://doi.org/10.1213/ANE.0b013e31824181e7
  38. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, Bartolomucci A, Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A. 2001;98:12796-12801. https://doi.org/10.1073/pnas.211427898
  39. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS. Stressinduced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A. 2004;101:3973-3978. https://doi.org/10.1073/pnas.0400208101
  40. Uzbay TI. Tianeptine: potential influences on neuroplasticity and novel pharmacological effects. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:915-924. https://doi.org/10.1016/j.pnpbp.2007.08.007
  41. Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clin Neuropharmacol. 1988;11 Suppl 2:74S-82S.
  42. Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxiousdepressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology. 1989;22:41-48. https://doi.org/10.1159/000118590
  43. Wilde MI, Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs. 1995;49:411-439. https://doi.org/10.2165/00003495-199549030-00007
  44. Ejchel-Cohen TF, Wood GE, Wang JF, Barlow K, Nobrega JN, S McEwen B, Trevor Young L. Chronic restraint stress decreases the expression of glutathione S-transferase pi2 in the mouse hippocampus. Brain Res. 2006;1090:156-162. https://doi.org/10.1016/j.brainres.2006.03.062
  45. Magarinos AM, Li CJ, Gal Toth J, Bath KG, Jing D, Lee FS, McEwen BS. Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus. 2011;21:253-264. https://doi.org/10.1002/hipo.20744
  46. Nishiyori M, Uchida H, Nagai J, Araki K, Mukae T, Kishioka S, Ueda H. Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain. 2011;7:69.
  47. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985;85:367-370. https://doi.org/10.1007/BF00428203
  48. Keyhanfar F, Shamsi Meymandi M, Sepehri G, Rastegaryanzadeh R, Heravi G. Evaluation of antinociceptive effect of pregabalin in mice and its combination with tramadol using tail flick test. Iran J Pharm Res. 2013;12:483-493.
  49. Meymandi MS, Sepehri G, Mobasher M. Gabapentin enhances the analgesic response to morphine in acute model of pain in male rats. Pharmacol Biochem Behav. 2006;85:185-189. https://doi.org/10.1016/j.pbb.2006.07.037
  50. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77-88. https://doi.org/10.1016/0304-3959(88)90026-7
  51. Reddyjarugu B, Pavek T, Southard T, Barry J, Singh B. Analgesic efficacy of firocoxib, a selective inhibitor of cyclooxygenase 2, in a mouse model of incisional pain. J Am Assoc Lab Anim Sci. 2015;54:405-410.
  52. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med. 2004;10:712-718. https://doi.org/10.1038/nm1060
  53. Rashid MH, Inoue M, Toda K, Ueda H. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther. 2004;309:380-387. https://doi.org/10.1124/jpet.103.060582
  54. Morley-Fletcher S, Darnaudery M, Koehl M, Casolini P, Van Reeth O, Maccari S. Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res. 2003;989:246-251. https://doi.org/10.1016/S0006-8993(03)03293-1
  55. Joo J, Lee S, Nah SS, Kim YO, Kim DS, Shim SH, Hwangbo Y, Kim HK, Kwon JT, Kim JW, Song HY, Kim HJ. Lasp1 is down-regulated in NMDA receptor antagonist-treated mice and implicated in human schizophrenia susceptibility. J Psychiatr Res. 2013;47:105-112. https://doi.org/10.1016/j.jpsychires.2012.09.005
  56. Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, Bardoni R. BDNF as a pain modulator. Prog Neurobiol. 2008;85:297-317. https://doi.org/10.1016/j.pneurobio.2008.04.004
  57. Imbe H, Iwai-Liao Y, Senba E. Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci. 2006;11:2179-2192. https://doi.org/10.2741/1960
  58. Nowacka MM, Paul-Samojedny M, Bielecka AM, Plewka D, Czekaj P, Obuchowicz E. LPS reduces BDNF and VEGF expression in the structures of the HPA axis of chronic social stressed female rats. Neuropeptides. 2015;54:17-27. https://doi.org/10.1016/j.npep.2015.09.003
  59. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT. 1998;14:181-193.
  60. Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:722-729. https://doi.org/10.1016/j.pnpbp.2010.04.011
  61. Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl). 2005;179:769-780. https://doi.org/10.1007/s00213-004-2103-4
  62. Mizuki I, Sato A, Matsuo A, Suyama Y, Suzuki J, Makita A. Clonal structure, seed set, and self-pollination rate in mass-flowering bamboo species during off-year flowering events. PLoS One. 2014;9:e105051. https://doi.org/10.1371/journal.pone.0105051
  63. Duric V, McCarson KE. Effects of analgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. J Pharmacol Exp Ther. 2006;319:1235-1243. https://doi.org/10.1124/jpet.106.109470
  64. Kremer M, Yalcin I, Nexon L, Wurtz X, Ceredig RA, Daniel D, Hawkes RA, Salvat E, Barrot M. The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system. Mol Pain. 2016;12:1744806916633477.
  65. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454.
  66. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96:399-409. https://doi.org/10.1111/j.1742-7843.2005.pto_96696601.x
  67. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135-144. https://doi.org/10.1016/0304-3959(90)91157-E
  68. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256. https://doi.org/10.1056/NEJM199205073261904
  69. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547-552. https://doi.org/10.1038/clpt.1992.183

Cited by

  1. Role of the Prefrontal Cortex in Pain Processing vol.56, pp.2, 2017, https://doi.org/10.1007/s12035-018-1130-9
  2. Psychotropic Drugs for the Management of Chronic Pain and Itch vol.12, pp.2, 2017, https://doi.org/10.3390/ph12020099
  3. The Medial Prefrontal Cortex as a Central Hub for Mental Comorbidities Associated with Chronic Pain vol.21, pp.10, 2017, https://doi.org/10.3390/ijms21103440
  4. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update vol.22, pp.8, 2017, https://doi.org/10.3390/ijms22083891